RAPAMUNE 2 mg (Rapamune 2 mg)
Generic Name: sirolimus
Pill with imprint RAPAMUNE 2 mg is Beige, Three-sided and has been identified as Rapamune 2 mg. It is supplied by Wyeth-Ayerst Laboratories.
Rapamune is used in the treatment of lymphangioleiomyomatosis; organ transplant, rejection prophylaxis and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Rapamune 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RAPAMUNE 2 mg
Rapamune
- Generic Name:
- sirolimus
- Imprint:
- RAPAMUNE 2 mg
- Strength:
- 2 mg
- Color:
- Beige
- Shape:
- Three-sided
- Availability:
- Prescription only
- Drug Class:
- MTOR inhibitors
Selective immunosuppressants - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Wyeth-Ayerst Laboratories
- National Drug Code (NDC):
- 00008-1032
More about Rapamune (sirolimus)
- Rapamune Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- Generic Availability
- Drug class: mTOR inhibitors
Consumer resources
- Rapamune
- Rapamune (Sirolimus Oral Solution)
- Rapamune (Sirolimus Tablets)
- Rapamune (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
